Demand for liver transplant for NASH set to continue rising

August 24, 2017

(HealthDay)—Given population obesity trends, the increase in the demand for liver transplantation (LT) for nonalcoholic steatohepatitis (NASH) noted since 2000 is expected to continue, according to a study published online Aug. 17 in Hepatology.

Neehar D. Parikh, M.D., from the University of Michigan in Ann Arbor, and colleagues examined the temporal trend behind the increase in and NASH-related additions to the LT waitlist in the United States and made projections for future NASH burden on the LT waitlist. Data on the number of NASH-related LT waitlist additions were obtained from the Organ Procurement and Transplantation Network database from 2000 to 2014. During the same time period, data on the obese U.S. population were obtained from the U.S. Census Bureau and the National Health and Nutrition Examination Survey.

The researchers observed a significant increase of 44.9 percent in the proportion of obese individuals from 2000 to 2014, and the number of NASH-related annual waitlist additions increased from 391 to 1,605. In derivation and validation cohorts, there was a strong correlation for increase in the prevalence of obesity and LT waitlist additions nine years later (R² = 0.9). Between 2016 and 2030, the annual NASH-related waitlist additions were expected to increase by 55.4 percent. Significant regional variation was seen in obesity rates and the expected increase in NASH-related additions (P < 0.01).

"Continued public health efforts to curb obesity prevalence are needed to reduce the projected future burden of NASH," the authors write.

Explore further: Study sheds light on immune responses driving obesity-induced liver disease

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Study sheds light on immune responses driving obesity-induced liver disease

June 28, 2017
New findings from mouse models reveal that the type of immune response that helps maintain healthy metabolism in fatty tissues, called type 2 immunity, also drives obesity-induced nonalcoholic fatty liver disease (NAFLD). ...

NASH ID'd by mass spectrometry-based profiling, clinical variables

October 6, 2016
(HealthDay)—Mass spectrometry (MS)-based profiling combined with clinical variables can identify nonalcoholic steatohepatitis (NASH), according to a study published in the October issue of Clinical Gastroenterology and ...

Sculpture to honor 'Beautiful Mind' mathematician Nash, wife

June 21, 2017
A sculpture honoring famed mathematician John Nash and his wife will be erected in the New Jersey town where they spent their last years.

Weight loss benefits NASH, no matter how it's done

August 24, 2015
(HealthDay)—Weight loss can improve nonalcoholic steatohepatitis (NASH) in obese or overweight people, whether excess pounds are shed through lifestyle changes or weight-loss surgery, according to research published in ...

Obesity and diabetes epidemics spur increase in nonalcoholic steatohepatitis

December 14, 2011
Nonalcoholic steatohepatitis (NASH) occurs when fat builds up in the liver. This accumulation of fat damages the liver and leads to cirrhosis. NASH is rapidly increasing in the U.S. mainly related to the epidemics of obesity ...

Fatty liver: Turning off TAZ reverses disease

October 27, 2016
Scientists at Columbia University Medical Center (CUMC) have identified a factor in liver cells that is responsible for turning a relatively benign liver condition, present in 30 percent of U.S. adults, into a serious disease ...

Recommended for you

Experimental vaccine shows promise in preventing TB

September 25, 2018
(HealthDay)—Tuberculosis remains the most lethal of infectious diseases worldwide, killing more than 1.6 million people a year. But researchers say a new vaccine might prevent half of full-blown illnesses in infected people ...

Researchers seek vaccine for 'traveler's diarrhea'

September 25, 2018
Every year, millions of people have vacations and business trips ruined when they succumb to "traveler's diarrhea" during their journeys. A major cause of traveler's diarrhea is bacteria called Enterotoxigenic E. coli, or ...

Many doctors in India miss TB signs: study

September 25, 2018
Many private sector doctors in India miss the signs of tuberculosis and therefore provide patients inadequate treatment, according to a new study published Tuesday involving people hired to act out the symptoms.

New way of determining treatment for staph infections cuts antibiotic use

September 25, 2018
Using a clinical checklist to identify eligible patients, doctors were able to shorten the antibiotic duration for patients with uncomplicated staphylococcal bloodstream infections by nearly two days, Duke Health researchers ...

Breakthrough in designing a better Salmonella vaccine

September 24, 2018
UC Davis researchers announce in the Proceedings of the National Academy of Sciences this week a breakthrough in understanding which cells afford optimal protection against Salmonella infection—a critical step in developing ...

Antifungal agent found to be possible treatment for porphyria

September 24, 2018
A large team of researchers from Spain, France and the U.S. has found that a common antifungal agent might be useful as a treatment for a rare type of porphyria. In their paper published in the journal Science Translational ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.